Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
31 Jan 2025
See more US accelerator Braid Theory sets up European headquarters in Barcelona to boost blue economyUS accelerator Braid Theory sets up European headquarters in Barcelona to boost blue economy
-
30 Jan 2025
See more Repsol to invest over €800M in the Tarragona Ecoplant, a pioneering project in Europe to produce renewable methanolRepsol to invest over €800M in the Tarragona Ecoplant, a pioneering project in Europe to produce renewable methanol
-
27 Jan 2025
See more Catalonia's Audiovisual industry grows 14% in one year, representing 3% of GDP with €8.636 billion in revenueCatalonia's Audiovisual industry grows 14% in one year, representing 3% of GDP with €8.636 billion in revenue
-
22 Jan 2025
See more Airbus GeoTech: How Catalonia’s innovation and talent drive Geospatial Data ExcellenceAirbus GeoTech: How Catalonia’s innovation and talent drive Geospatial Data Excellence
